These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22581276)

  • 21. Role of probiotic therapy in IBD.
    Isaacs K; Herfarth H
    Inflamm Bowel Dis; 2008 Nov; 14(11):1597-605. PubMed ID: 18421762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics in the treatment of human inflammatory bowel diseases: update 2008.
    Fedorak RN; Dieleman LA
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S97-103. PubMed ID: 18542034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Probiotics in chronic inflammatory bowel disease].
    Böhm S; Kruis W
    MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics in luminal gastroenterology: the current state of play.
    Andrews JM; Tan M
    Intern Med J; 2012 Dec; 42(12):1287-91. PubMed ID: 23252997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.
    LeBlanc JF; Segal JP; de Campos Braz LM; Hart AL
    Nutrients; 2021 May; 13(6):. PubMed ID: 34071065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics in the management of Crohn's disease and ulcerative colitis.
    Müllner K; Miheller P; Herszényi L; Tulassay Z
    Curr Pharm Des; 2014; 20(28):4556-60. PubMed ID: 24180407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics in the Treatment of Inflammatory Bowel Disease.
    Guandalini S; Sansotta N
    Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.
    Scarpato E; Russo M; Staiano A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S7-S9. PubMed ID: 30036240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics: do they help to control intestinal inflammation?
    Böhm SK; Kruis W
    Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Probiotics in Crohn's Disease and in Pouchitis.
    Guslandi M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S46-9. PubMed ID: 26447964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
    Mitsuyama K; Toyonaga A; Sata M
    J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.